Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 4:13 p.m.

/zigman2/quotes/200043077/composite

$

45.02

Change

0.00 0.00%

Volume

Volume 10,239

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Today's close

$ 47.64

$ 45.02

Change

-2.62 -5.50%

Day low

Day high

$44.12

$47.67

Open

52 week low

52 week high

$43.81

$93.94

Open

Insider Actions for Denali Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/10/2021 Vicki L. Sato
Director
660   Disposition at $53.3 per share. 35,178
11/10/2021 Vicki L. Sato
Director
1,006   Disposition at $52.49 per share. 52,804
11/04/2021 Alexander O. Schuth
COO and Secretary
3,283   Disposition at $53.23 per share. 174,754
11/04/2021 Alexander O. Schuth
COO and Secretary
6,717   Disposition at $52.65 per share. 353,650
11/01/2021 Ryan J. Watts
President and CEO; Director
16,674   Disposition at $49.87 per share. 831,532
11/01/2021 Ryan J. Watts
President and CEO; Director
1,659   Disposition at $48.61 per share. 80,643
11/01/2021 Vicki L. Sato
Director
1,666   Disposition at $50.05 per share. 83,383
10/04/2021 Alexander O. Schuth
COO and Secretary
4,006   Disposition at $51.04 per share. 204,466
10/04/2021 Alexander O. Schuth
COO and Secretary
5,994   Disposition at $50.24 per share. 301,138
10/01/2021 Ryan J. Watts
President and CEO; Director
4,247   Disposition at $50.99 per share. 216,554
10/01/2021 Ryan J. Watts
President and CEO; Director
10,782   Disposition at $50.44 per share. 543,844
10/01/2021 Ryan J. Watts
President and CEO; Director
3,304   Disposition at $49.38 per share. 163,151
09/20/2021 Alexander O. Schuth
COO and Secretary
9,045   Derivative/Non-derivative trans. at $0.68 per share. 6,150
09/15/2021 Vicki L. Sato
Director
140   Disposition at $54.76 per share. 7,666
09/15/2021 Vicki L. Sato
Director
620   Disposition at $53.92 per share. 33,430
09/15/2021 Vicki L. Sato
Director
676   Disposition at $53.03 per share. 35,848
09/15/2021 Vicki L. Sato
Director
230   Disposition at $52.28 per share. 12,024
09/01/2021 Ryan J. Watts
President and CEO; Director
10,892   Disposition at $54.92 per share. 598,188
09/01/2021 Ryan J. Watts
President and CEO; Director
7,441   Disposition at $54.27 per share. 403,823
08/23/2021 Carole Ho
Chief Medical Officer
6,143   Disposition at $48.91 per share. 300,454
08/19/2021 Ryan J. Watts
President and CEO; Director
750   Disposition at $49.97 per share. 37,477
08/19/2021 Ryan J. Watts
President and CEO; Director
1,626   Disposition at $49.38 per share. 80,291
08/19/2021 Steve E. Krognes
CFO and Treasurer
200   Disposition at $50.07 per share. 10,014
08/19/2021 Steve E. Krognes
CFO and Treasurer
2,085   Disposition at $49.52 per share. 103,249
08/19/2021 Alexander O. Schuth
COO and Secretary
196   Disposition at $50.1 per share. 9,819
08/19/2021 Alexander O. Schuth
COO and Secretary
2,348   Disposition at $49.56 per share. 116,366
08/19/2021 Carole Ho
Chief Medical Officer
1,144   Disposition at $49.91 per share. 57,097
08/19/2021 Carole Ho
Chief Medical Officer
1,402   Disposition at $49.31 per share. 69,132

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
18 Sales
9,045
79,997
Last 6 months
18 Purchases
51 Sales
139,533
280,266
Last 12 months
25 Purchases
188 Sales
171,674
3,681,555

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Chief Operating Officer & Secretary
Mr. Steve E. Krognes
Treasurer, Chief Financial & Accounting Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.